DIA Announces New Board of Directors at 2023 Global Annual Meeting

Acknowledging our exceptional Board of Directors, both incoming and outgoing

WASHINGTON--(BUSINESS WIRE)--Today, at the DIA (Drug Information Association) Global Annual Meeting in Boston, MA, the organization welcomed fresh faces to their multidisciplinary Board of Directors and expressed gratitude to the outgoing Directors for their many contributions.

“DIA 2023 Global Annual Meeting, being held this week in Boston, includes over 5,000 patients, professionals, organizations, passionate students and government representatives from across the international life science communities, all working together to illuminate the path to the best healthcare outcomes worldwide.” says Marwan Fathallah, President, and GCE, DIA. “This meeting is the perfect venue to introduce our newly appointed DIA Board of Directors, with each member having specific and extensive industry experience, I am confident they will help us strategize the most successful pathways to the future of healthcare. I want to personally acknowledge our outgoing members; DIA will be forever grateful for their hard work and dedication.”

DIA 2023-2024 Board of Directors

_{*New Members}

• Michael Rosenblatt, MD Chair
• Kihito Takahashi, MD, PhD Chair-elect
• Cynthia Verst, PharmD, MS Past Chair
• Marwan Fathallah, MBA, DIA President & GCE
• Junaid Bajwa, MD Director
• Jens Grueger, PhD Director*
• Peter Honig, MD, MPH Director
• Frank Jiang, MD, PhD Director
• Tatyana Kosheleva, CPA, Director
• Jason Monteleone, CPA, MBA Director
• Chockalingam Palaniappan, PhD* Director
• Peter Sorger, PhD Director
• Peter Ronco, Director*
• Rachel Zhang, MBA Director
• Craig Cara, CPA Board Observer*
• Wendy Yan, MBA Board Observer*

DIA thanks the incredible work of these exiting Directors:

• Michael Romano, CPA
• Judith Ng-Cashin, MD
• Michael Devoy, MD
• Karin Van Baelen

While maintaining neutral, transparent, and collaborative engagement, DIA’s Board of Directors volunteer to provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments.

About DIA

DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have affected healthcare outcomes, by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities.

DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan). Learn more and register for the DIA Global Annual Meeting 2023 at DIAglobal.org/DIA2023. For live updates, search social media with #DIA2023, and connect with DIA on Twitter, LinkedIn, Facebook, and YouTube.